1. Home
  2. ACET vs CEV Comparison

ACET vs CEV Comparison

Compare ACET & CEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$8.45

Market Cap

71.3M

Sector

Health Care

ML Signal

HOLD

Logo Eaton Vance California Municipal Income Trust Shares of Beneficial Interest

CEV

Eaton Vance California Municipal Income Trust Shares of Beneficial Interest

HOLD

Current Price

$10.10

Market Cap

70.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACET
CEV
Founded
1947
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
71.3M
70.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ACET
CEV
Price
$8.45
$10.10
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$96.67
N/A
AVG Volume (30 Days)
237.2K
19.6K
Earning Date
11-05-2025
01-01-0001
Dividend Yield
N/A
4.23%
EPS Growth
N/A
N/A
EPS
N/A
0.36
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$29.36
Revenue Growth
N/A
N/A
52 Week Low
$7.15
$8.83
52 Week High
$17.44
$10.91

Technical Indicators

Market Signals
Indicator
ACET
CEV
Relative Strength Index (RSI) 91.35 46.44
Support Level $7.94 $9.98
Resistance Level $9.05 $10.10
Average True Range (ATR) 0.31 0.06
MACD 0.84 0.00
Stochastic Oscillator 92.14 73.61

Price Performance

Historical Comparison
ACET
CEV

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

About CEV Eaton Vance California Municipal Income Trust Shares of Beneficial Interest

Eaton Vance CA Muni Income Trust is a non-diversified closed-end investment company. The company's investment objective is to provide current income exempt from regular federal income tax and California state personal income taxes. It invests in municipal obligations, issued by the State of California or its political subdivisions, agencies, authorities and instrumentalities and also has some exposure to corporate bonds.

Share on Social Networks: